PA8580101A1 - Un nuevo producto para el combate de garrapatas y el proceso para la preparacion - Google Patents
Un nuevo producto para el combate de garrapatas y el proceso para la preparacionInfo
- Publication number
- PA8580101A1 PA8580101A1 PA20038580101A PA8580101A PA8580101A1 PA 8580101 A1 PA8580101 A1 PA 8580101A1 PA 20038580101 A PA20038580101 A PA 20038580101A PA 8580101 A PA8580101 A PA 8580101A PA 8580101 A1 PA8580101 A1 PA 8580101A1
- Authority
- PA
- Panama
- Prior art keywords
- ticket
- eprinomectine
- tickets
- another object
- live weight
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 235000013365 dairy product Nutrition 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 150000002678 macrocyclic compounds Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
UN OBJETO DE LA PRESENTE INVENCION ES PRESENTAR EL PRINCIPIO ACTIVO EPRINOMECTINA POR LA VIA INYECTABLE- LA EPINOMECTRINA (4-EPI-ACETYLAMINO-4-DESOXY AVERMECTIN B1) ES UNA MOLECULA DE ULTIMA GENERACION DE LA CLASE DE LAS LACTOSAS MACROCICLICAS. ESTA MILECULA HA SIDO INICIALMENTE POR LA VIA TOPICA EN UNA DOSIS DE 500 HG/KG DE PESO VIVO. LA VIA PROPUESTA POR EPRINOVAX DETERMINA SIMILAR ACCION TERAPEUTICA EN DOSIS MUY INFERIORES: 200-250 UG/KG DE PESO VIVO. OTRO OBJETO DE ESTA INVENCION ES UNIR EN UN MISMO VEHICULO, EL FARMACO EPRINOMECTINA Y LOS ANTIGENOS ESPECIFICOS CONTRA LA GARRAPATA. DE ESTA FORMA, EL PRODUCTOR LECHERO O GANADERO, AL MISMO TIEMPO QUE DESPARASITA SUS ANIMALES, VA GENERANDO EN SU REBAÑO UNA INMUNIDAD CONTRA LAS GARRAPATAS, QUE PUEDE PERMANECER POR UN PERIODO DE DOS AÑOS. AUN MAS, OTRO OBJETO DE LA INVENCION ES QUE EL NOVEDODO VEHICULO DETERMINA UN EFECTO DE LIBERACION RETARDADA DE LOS PRINCIPIOS ACTIVOS, LO QUE VA A DETERMINAR UN MAYOR ESPACIO DE TIEMPO ENTRE LOS TRATAMIENTOS. UN NUEVO OBJETO DE LA INVENCION ES CONSEGUIR UNA DISMINUCION GRADUAL DE LA CANTIDAD DE DROGA INSECTICIDA AL COMBATE DE LAS GARRAPATAS, INFLUYENDO DRASTICAMENTE EN TODOS LOS IMPACTOS AMBIENTALES QUE ESTOS PRODUCTOS PUEDAN CAUSAR.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY27412A UY27412A1 (es) | 2002-08-12 | 2002-08-12 | Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8580101A1 true PA8580101A1 (es) | 2004-10-08 |
Family
ID=30444532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20038580101A PA8580101A1 (es) | 2002-08-12 | 2003-08-12 | Un nuevo producto para el combate de garrapatas y el proceso para la preparacion |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20050118222A1 (es) |
| AP (1) | AP2003002844A0 (es) |
| AR (1) | AR040854A1 (es) |
| AU (1) | AU2003234877A1 (es) |
| BR (1) | BR0303315A (es) |
| DZ (1) | DZ3496A1 (es) |
| EG (1) | EG24434A (es) |
| ES (1) | ES2297954B1 (es) |
| FR (1) | FR2845004B1 (es) |
| IT (1) | ITRM20030396A1 (es) |
| MX (1) | MXPA03007205A (es) |
| NZ (1) | NZ527533A (es) |
| PA (1) | PA8580101A1 (es) |
| UY (1) | UY27412A1 (es) |
| ZA (1) | ZA200306184B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8313752B2 (en) * | 2009-04-14 | 2012-11-20 | Merial Limited | Macrocyclic lactone combination compositions, vaccines and methods for producing same |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2361110A1 (fr) * | 1976-08-13 | 1978-03-10 | Wellcome Found | Medicaments anthelminthiques renfermant une association synergique de substances actives |
| NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
| LU86351A1 (fr) * | 1986-03-12 | 1987-11-11 | Oreal | Composes benzopyrannyl et benzothiopyrannyl benzoiques,leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
| NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
| TW410158B (en) * | 1995-11-30 | 2000-11-01 | Chemo Sero Therapeut Res Inst | Oil adjuvant vaccine and method for preparing same |
| CA2259469A1 (en) * | 1996-06-05 | 1997-12-11 | Ashmont Holdings Limited | Injectable compositions |
| US6017757A (en) * | 1997-02-20 | 2000-01-25 | Mississippi State University | Isolated viable nematode intestinal cells |
| UY25089A1 (es) * | 1997-07-10 | 2000-08-21 | Hoechst Roussel Vet Gmbh | Vacunas no acuosas |
| CN1205921C (zh) * | 1997-12-03 | 2005-06-15 | 麦克公司 | 含有氢化蓖麻油的长效注射制剂 |
| US6733767B2 (en) * | 1998-03-19 | 2004-05-11 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| AU1940301A (en) * | 1999-12-03 | 2001-06-12 | Yale University | Tick antigens and compositions and methods comprising them |
| AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
| PE20011289A1 (es) * | 2000-04-07 | 2001-12-21 | Upjohn Co | Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles |
| WO2002028387A1 (en) * | 2000-10-03 | 2002-04-11 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
| FR2839614B1 (fr) * | 2002-05-14 | 2004-08-13 | Virbac Sa | Nouvelles compositions orales huileuses antiparasitaires |
-
2002
- 2002-08-12 UY UY27412A patent/UY27412A1/es not_active Application Discontinuation
-
2003
- 2003-08-11 AR AR20030102907A patent/AR040854A1/es not_active Application Discontinuation
- 2003-08-11 ZA ZA200306184A patent/ZA200306184B/xx unknown
- 2003-08-12 PA PA20038580101A patent/PA8580101A1/es unknown
- 2003-08-12 IT IT000396A patent/ITRM20030396A1/it unknown
- 2003-08-12 FR FR0309874A patent/FR2845004B1/fr not_active Expired - Fee Related
- 2003-08-12 AU AU2003234877A patent/AU2003234877A1/en not_active Abandoned
- 2003-08-12 DZ DZ030186A patent/DZ3496A1/fr active
- 2003-08-12 US US10/639,644 patent/US20050118222A1/en not_active Abandoned
- 2003-08-12 NZ NZ527533A patent/NZ527533A/xx not_active IP Right Cessation
- 2003-08-12 ES ES200301944A patent/ES2297954B1/es not_active Expired - Fee Related
- 2003-08-12 EG EG2003080793A patent/EG24434A/xx active
- 2003-08-12 BR BR0303315-5A patent/BR0303315A/pt not_active IP Right Cessation
- 2003-08-12 AP APAP/P/2003/002844A patent/AP2003002844A0/en unknown
- 2003-08-12 MX MXPA03007205A patent/MXPA03007205A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM20030396A1 (it) | 2004-02-13 |
| EG24434A (en) | 2009-06-25 |
| BR0303315A (pt) | 2004-06-08 |
| AU2003234877A1 (en) | 2004-02-26 |
| ES2297954B1 (es) | 2009-09-28 |
| AP2003002844A0 (en) | 2003-09-30 |
| ITRM20030396A0 (it) | 2003-08-12 |
| AR040854A1 (es) | 2005-04-20 |
| NZ527533A (en) | 2005-04-29 |
| ES2297954A1 (es) | 2008-05-01 |
| FR2845004B1 (fr) | 2007-08-03 |
| ZA200306184B (en) | 2005-01-05 |
| MXPA03007205A (es) | 2007-09-07 |
| US20050118222A1 (en) | 2005-06-02 |
| DZ3496A1 (fr) | 2005-10-08 |
| FR2845004A1 (fr) | 2004-04-02 |
| UY27412A1 (es) | 2003-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122417T1 (el) | Μεθοδοι και συνθεσεις για παρατεταμενη παροχη φαρμακων | |
| BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
| PE20160195A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
| ECSP066990A (es) | Formulaciones con liberación controlada de principio activo que contienen vardenafilo | |
| BRPI0707235B8 (pt) | formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual | |
| GT200500378A (es) | Macrolidos | |
| BR0213653A (pt) | Formulação farmacêutica que contém o 3-(3-dimetil-amino1-etil-2metil-propil) fenol e proporciona uma liberação retardada do ingrediente ativo | |
| ES2146300T3 (es) | Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos. | |
| BRPI1014783A2 (pt) | formulações farmacêuticas e métodos para tratar infecções do trato respiratório | |
| PA8546101A1 (es) | Un antagonista de a2a en combinacion con un agente anticolinergico para el tratamiento de enfermedades obstructivas de las vias aereas | |
| AR023966A1 (es) | Una composicion farmaceutica para la prevencion y/o el tratamiento de la enfermedad de parkinson y los sintomas concomitantes de la misma, y el uso de unantagonista dual receptor de adenosina a1 a2a para preparar dicha composicion | |
| ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
| CO6270217A2 (es) | Formulaciones galenicas de alisquireno y valsartan | |
| PA8616201A1 (es) | Composiciones farmaceuticas de liberacion sostenida | |
| BR9914419A (pt) | Terapia para melhoria da percepção | |
| BR112019005318A2 (pt) | compostos de aza-indazol para uso em lesões no tendão e/ou ligamento | |
| BR112012020377A8 (pt) | utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial | |
| PA8580101A1 (es) | Un nuevo producto para el combate de garrapatas y el proceso para la preparacion | |
| BR112019005578A2 (pt) | compostos de indazol para uso em lesões no tendão e/ou ligamento | |
| IL250852B (en) | Periodontal preparation | |
| ECSP088285A (es) | 3-(2-dimetilaminometil ciclohexil) fenol formulación retardada. | |
| CR9074A (es) | Agente para la profilaxis o tratamiento del sindrome metabolico | |
| HRP20110127T1 (hr) | Aksomadol za liječenje kod artritisa | |
| GT201000064A (es) | Formulaciones galénicas de alisquireno | |
| DOP2003000688A (es) | Un nuevo producto para el cambate de garrapatas y el proceso para la preparacion del producto |